The commonest pathogenic variant of SFTPC, I73T, mislocalises to the plasma membrane and causes AT2 dysfunction via a toxic gain-of-function effect leading to ILD (Brasch et al, 2004; Alysandratos et al, 2021). Here, SFTPC is linked to interstitial lung disease.